Lymphocyte mitochondrial biomarkers in asymptomatic HIV-1-infected individuals treated with nucleoside reverse transcriptase inhibitors

AIDS

Volumn 16, Issue 18, 2002, Pages 2485-2487

  Henry, Keith ^a,b   Erice, Alejo ^b   Balfour Jr , Henry H ^b   Schmeling, Max ^b   Berthiaume, Jessica ^c   Wallace, Ken ^c  

^a REGIONS HOSPITAL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA DULUTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AMPRENAVIR; BIOLOGICAL MARKER; CELL NUCLEUS DNA; DIDANOSINE; HYDROXYUREA; LAMIVUDINE; MITOCHONDRIAL DNA; NEVIRAPINE; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; TENOFOVIR; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MALE; MITOCHONDRIAL GENETICS; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PERIPHERAL LYMPHOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; BIOLOGICAL MARKERS; COHORT STUDIES; CYTOCHROME B GROUP; DNA, MITOCHONDRIAL; HIV INFECTIONS; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; LYMPHOCYTES; MIDDLE AGED; MITOCHONDRIAL DISEASES; NUCLEOSIDES; PYRUVATE KINASE; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 0037032948     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200212060-00018     Document Type: Article

References (8)

1. Palella FJ Jr, Delaney KM, Morman AC, Loveless MO, Fuhrer J, Satten GA, et al. The HIV outpatient study investigators: declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338:853-860.
2. Brinkman K, ter Hofstede HJM, Burger DM, Smeitink JAM, Koopmans PP. Adverse effects of reverse transcriptase inhibitors: Mitochondrial toxicity as common pathway. AIDS 1998; 12:1735-1744.
3. Kakuda T, Brundage RC, Anderson PL and Fletcher CV. Nucleoside reverse transciptase inhibitor-induced mitochondrial toxicity as an etiology for lipodystrophy [Letter]. AIDS 1999; 13:2311-2312.
4. Carr A, Miller J, Law M and Cooper DA. A syndrome of lipoatrophy, lactic academia and liver dysfunction associated with HIV nucleoside analogue therapy: Contribution to protease inhibitor-related lipodystrophy syndrome. AIDS 2000; 14:F25-F32.
5. Cote HCF, Brumme ZL, Craib KIP, Alexander CS, Wynhoven B, Ting L, et al. Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients. N Engl J Med 2002; 346:811-820.
6. Cossarizza A, Pinto M, Moretti L, et al. Mitochondrial functionality and mitochondrial DNA content in lymphocytes of vertically infected human immunodeficiency virus-positive childred with highly active antiretroviral therapy-related lipodystrophy. J Infect Dis 2002; 1B5:299-305.
7. McComsey G, Tan DI, Lederman M, Wilson E, Wong LJ. Analysis of the mitochondrial DNA genome in the peripheral blood leukocytes of HIV-infected patients with or without lipoatrophy. AIDS 2002; 16:513-518.
8. Shikuma C, Hu N, Milne C, Yost F, Waslien C, Shimizu S and Shiramizu B. Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV infected individuals with peripheral lipostrophy. AIDS 2001; 15:1801-1809.